International Journal of Allergy Medications最新文献

{"title":"H1-Antihistamines for Allergic Diseases: Old Aged but Not Old-Fashioned Drugs","authors":"Ricci Luisa, Furci Fabiana, S. Isola","doi":"10.23937/2572-3308.1510037","DOIUrl":"https://doi.org/10.23937/2572-3308.1510037","url":null,"abstract":"Citation: Ricciardi L, Furci F, Stefania I (2019) H1-Antihistamines for Allergic Diseases: Old Aged but Not Old-Fashioned Drugs. Int J Aller Medications 5:037. doi.org/10.23937/2572-3308.1510037 Accepted: March 02, 2019: Published: March 04, 2019 Copyright: © 2019 Ricciardi L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"162 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132856915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical and Spirometric Characteristics of Premenstrual Asthma","authors":"S. Aissani, I. Ararem, H. Haouichat, M. Haffaf, A. Zitouni","doi":"10.23937/2572-3308.1510041","DOIUrl":"https://doi.org/10.23937/2572-3308.1510041","url":null,"abstract":"Citation: Aissani S, Ararem I, Haouichat H, Haffaf ME, Zitouni A (2019) Clinical and Spirometric Characteristics of Premenstrual Asthma. Int J Aller Medications 5:041. doi.org/10.23937/2572-3308.1510041 Accepted: June 04, 2019: Published: June 06, 2019 Copyright: © 2019 Aissani S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123038750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anaphylaxis to Water Caltrop (Singoda Flour): A Case Report","authors":"O. Mohamed, T. Osborne, J. Heslegrave, M. Krishna","doi":"10.23937/2572-3308.1510040","DOIUrl":"https://doi.org/10.23937/2572-3308.1510040","url":null,"abstract":"","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"202 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127584124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?","authors":"M. Skov","doi":"10.23937/2572-3308.1510039","DOIUrl":"https://doi.org/10.23937/2572-3308.1510039","url":null,"abstract":"Citation: Skov M (2019) Anti-IgE (Omalizumab) in the Management of ABPA among Cystic Fibrosis Patients: An Alternative to Steroid Treatment?. Int J Aller Medications 5:039. doi.org/10.23937/25723308.1510039 Accepted: May 23, 2019: Published: May 25, 2019 Copyright: © 2019 Skov M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115798744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Burden of Allergic Rhinitis and Impact of GRAZAX® Grass Allergy Immunotherapy Treatment on Quality of Life in Germany and The Netherlands: Results from A Qualitative Study","authors":"N. Germain, R. V. Wijk, S. Aballéa, L. Abetz-Webb, A. Domdey, M. Romano, M. Toumi","doi":"10.23937/2572-3308.1510038","DOIUrl":"https://doi.org/10.23937/2572-3308.1510038","url":null,"abstract":"Background: Allergic rhinitis is a major chronic respiratory disease that affects between 10% and 30% of adults and up to 40% of children globally. The purpose of this study was to understand the impact of allergic rhinitis and subsequent GRAZAX® grass allergy immunotherapy (AIT) treatment on adults’ and adolescents’ quality of life. Methods: Clinicians treating allergic rhinitis in the Netherlands and Germany recruited adults and adolescents who had received at least 3 years of GRAZAX® treatment. Telephone interviews were conducted with patients to explore their experience of allergic rhinitis and AIT. Interview transcripts were analyzed using grounded theory methods. Saturation analysis was conducted for impact-related concepts. 3 allergists were also interviewed to explore their experience of treating allergic rhinitis. Results: 15 adults (aged 19-61) and 18 adolescents (aged 11-17) were interviewed. Clinicians and patients reported that before treatment with GRAZAX®, the most common allergic rhinitis symptoms were noseand eye-related. Together with coping strategies, these had considerable negative impacts on patients’ quality of life. Adults and adolescents reported notable improvement or disappearance of symptoms during treatment with GRAZAX®. Symptom reduction during treatment led to positive impacts on social, work/school, and physical functioning, with less need for impactful coping strategies. Some patients experienced oral side effects in the first months of AIT, though these resolved with time. Saturation of impact-related concepts was achieved. Conclusion: GRAZAX® treatment considerably improved allergic rhinitis symptoms and therefore impacted on daily life for patients during and after at least 3 years of treatment. Despite long recall periods, the consistency of reports between doctors, adolescents and adults, and achieving saturation suggest the robustness of the results; a three year course of treatment with GRAZAX® positively impacts quality of life and supports the existing clinical efficacy data on GRAZAX® treatment.","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"68 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121949319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thrombocytopenia in a Patient with Severe Combined Immune Deficiency: An Unusual Cause","authors":"S. Farrukh, Sumayli Safiah, Hakami Hasan, Khaliq Agha M Rehan, Gazlan Sulaiman Al, Alrayes Hasan, Al-Dawsari Ghuzayel, Fakih Riad El, Arnaout Rand","doi":"10.23937/2572-3308.1510035","DOIUrl":"https://doi.org/10.23937/2572-3308.1510035","url":null,"abstract":"Citation: Sheikh F, Sumayli S, Hakami H, Khaliq AMR, Al Gazlan S, et al. (2018) Thrombocytopenia in a Patient with Severe Combined Immune Deficiency: An Unusual Cause. Int J Aller Medications 4:035. doi.org/10.23937/2572-3308.1510035 Accepted: September 20, 2018: Published: September 22, 2018 Copyright: © 2018 Sheikh F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126915540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome","authors":"Foster Katharine J, Rodrigues Jonathan, Lee-Thorp Julia, Powell Sara, Azmeh Roua, Knutsen Alan P","doi":"10.23937/2572-3308.1510034","DOIUrl":"https://doi.org/10.23937/2572-3308.1510034","url":null,"abstract":"Citation: Foster KJ, Rodrigues J, Lee J, Powell S, Azmeh R, et al. (2018) Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome at a Single Children’s Hospital. Int J Aller Medications 4:034. doi. org/10.23937/2572-3308.1510034 Accepted: August 16, 2018: Published: August 18, 2018 Copyright: © 2018 Foster KJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133496302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Importance of Allergic Hypersensitivity to Medications","authors":"Miguel-RodrIguez Angel San, A. Alicia, MartIn-Armentia Sara, Martins Blanca, Estevan Mª Carmen Lozano, Peinado Irene Iglesias","doi":"10.23937/2572-3308.1510032","DOIUrl":"https://doi.org/10.23937/2572-3308.1510032","url":null,"abstract":"Citation: Miguel-Rodríguez AS, Armentia A, Martín-Armentia S, Martín-Armentia B, Estevan MCL, et al. (2018) Importance of Allergic Hypersensitivity to Medications. Int J Aller Medications 4:032. doi. org/10.23937/2572-3308.1510032 Accepted: August 06, 2018: Published: August 08, 2018 Copyright: © 2018 Miguel-Rodríguez AS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131894884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Glycosphopeptical and Specific Immunotherapy Effect in Allergic Rhinitis","authors":"Baltazar Becerril-Bautista, Darío Jímenez-Uscanga Rubén, E. María, Alonso-Bello César Daniel, Fernando Lozano-Patiño, C. P. M. del, L. Juárez-Santiago, Castrejón-Vázquez María Isabel","doi":"10.23937/2572-3308.1510036","DOIUrl":"https://doi.org/10.23937/2572-3308.1510036","url":null,"abstract":"Citation: Becerril-Bautista B, Jímenez-Uscanga RD, Vargas-Camaño ME, Alonso-Bello CD, Lozano-Patiño F, et al. (2018) Glycophosphopeptical and Specific Immunotherapy Effect in Allergic Rhinitis. Int J Aller Medications 4:036. doi.org/10.23937/2572-3308.1510036 Accepted: October 15, 2018: Published: October 17, 2018 Copyright: © 2018 Becerril-Bautista B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"1776 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129567118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vitamin D Levels in Patients with Anaphylaxis with or without Asthma Compared to the General Population","authors":"S. Farrukh, Khaliq Agha M Rehan, A SheikhQasim, Qahtani Abdul Hadi Al, Hashim Samia Al, Arnaout Rand, A. Rashid","doi":"10.23937/2572-3308.1510031","DOIUrl":"https://doi.org/10.23937/2572-3308.1510031","url":null,"abstract":"Citation: Sheikh F, Khaliq AMR, Sheikh QA, Al Qahtani AH, Al Hashim S, et al. (2018) Vitamin D Levels in Patients with Anaphylaxis with or without Asthma Compared to the General Population. Int J Aller Medications 4:031. doi.org/10.23937/2572-3308.1510031 Accepted: August 04, 2018: Published: August 06, 2018 Copyright: © 2018 Sheikh F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. International Journal of Allergy Medications","PeriodicalId":138186,"journal":{"name":"International Journal of Allergy Medications","volume":"101 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115444856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}